Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
ClinicalTrials.gov study NCT01266083. IPD Sharing: NO. Countries: 1. Publications: 1.
Combination Chemotherapy and Dasatinib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01238211. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Safety and Efficacy Study of Pracinostat With Azacitadine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01912274. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00607997. IPD Sharing: YES. Countries: 1. Publications: 1.
DEC-205/NY-ESO-1 Fusion Protein CDX-1401, Poly ICLC, Decitabine, and Nivolumab in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03358719. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT01546038. IPD Sharing: YES. Countries: 6. Publications: 6.
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00651261. IPD Sharing: Not stated. Countries: 2. Publications: 7.
Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01696084. IPD Sharing: Not stated. Countries: 2. Publications: 8.
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02728050. IPD Sharing: NO. Countries: 1. Publications: 1.
Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01802333. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Study of AG-120 (Ivosidenib) vs. Placebo in Combination With Azacitidine in Participants With Previously Untreated Acute Myeloid Leukemia With an IDH1 Mutation
ClinicalTrials.gov study NCT03173248. IPD Sharing: YES. Countries: 20. Publications: 3.
Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00658814. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ph I Study of Alvocidib and Cytarabine/Daunorubicin (7+3) in Patients With Newly Diagnosed Acute Myeloid Leukemia (AML).
ClinicalTrials.gov study NCT03298984. IPD Sharing: NO. Countries: 1. Publications: 1.
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00703820. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study of Ibrutinib in Subjects With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02351037. IPD Sharing: NO. Countries: 1. Publications: 1.
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
ClinicalTrials.gov study NCT04745676. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01303796. IPD Sharing: NO. Countries: 12. Publications: 1.
A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02954653. IPD Sharing: NO. Countries: 1. Publications: 1.
Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
ClinicalTrials.gov study NCT02275533. IPD Sharing: UNDECIDED. Countries: 2. Publications: 2.
A Study of ASP2215 (Gilteritinib) by Itself, ASP2215 Combined With Azacitidine or Azacitidine by Itself to Treat Adult Patients Who Have Recently Been Diagnosed With Acute Myeloid Leukemia With a FLT3
ClinicalTrials.gov study NCT02752035. IPD Sharing: YES. Countries: 13. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.